Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Cosgrove, CormacDellacecca, Emilia R
van den Berg, Joost H
Haanen, John B
Nishimura, Michael I
Le Poole, I Caroline
Bergmans, Hans E N
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Transgenerational transfer of gene-modified T cells.Published in
J Immunother Cancer 2019; 7(1):186PMID
31307533ae974a485f413a2113503eed53cd6c53
10.1186/s40425-019-0657-2
Scopus Count
Collections
Related articles
- Maternal CD4⁺ and CD8⁺ T cell tolerance towards a fetal minor histocompatibility antigen in T cell receptor transgenic mice.
- Authors: Perchellet AL, Jasti S, Petroff MG
- Issue date: 2013 Oct
- Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy.
- Authors: Hu HM, Winter H, Urba WJ, Fox BA
- Issue date: 2000 Oct 15
- MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
- Authors: Bosch JJ, Thompson JA, Srivastava MK, Iheagwara UK, Murray TG, Lotem M, Ksander BR, Ostrand-Rosenberg S
- Issue date: 2007 May 1
- Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
- Authors: Wu F, Zhang W, Shao H, Bo H, Shen H, Li J, Liu Y, Wang T, Ma W, Huang S
- Issue date: 2013 Oct 10
- Lentivector prime and vaccinia virus vector boost generate high-quality CD8 memory T cells and prevent autochthonous mouse melanoma.
- Authors: Xiao H, Peng Y, Hong Y, Liu Y, Guo ZS, Bartlett DL, Fu N, He Y
- Issue date: 2011 Aug 15